Information Provided By: 
Fly News Breaks for October 26, 2018
IRIX
Oct 26, 2018 | 05:59 EDT
Stifel analyst Jonathan Block started Iridex with a Buy rating and $9 price target. The analyst says his diligence identifies increasing traction for Cyclo G6, which he does not believe is properly reflected in the stock's current valuation. G6 utilizes Iridex's proprietary MicroPulse technology, which delivers laser energy using a mode that chops continuous wave laser beams into short, microsecond-long pulses in order to achieve a therapeutic response, while minimizing damage to tissue in the eye, the analyst points out.
News For IRIX From the Last 2 Days
There are no results for your query IRIX
